Abstract
Background Risk for Tourette’s and related tic disorders (CTD) derives from a combination of genetic and environmental factors. While multiple studies have demonstrated the importance of direct additive genetic variation for CTD, little is known about the role of cross-generational transmission of genetic risks, such as maternal effects. Here, we partition sources of variation on CTD risk into direct additive genetic effect and maternal effects.
Methods The study population consists of 2,522,677 individuals from the Swedish Medical Birth Register, born in Sweden between January 1, 1982, to December 31, 1990, and followed for a diagnosis of CTD through December 31, 2013.
Results We identified 6,227 (0.25%) individuals in the birth cohort diagnosed with CTD. Using generalized linear mixed models, we estimated 4.7% (95% CrI, 4.4%-4.8%) genetic maternal effects, 0.5% (95% CrI, 0.2%-7%) environmental maternal effects, and 61% (95% CrI, 59%-63%) direct additive genetic effects. Around 1% of genetic maternal effects were due to maternal effects from the individual with comorbid obsessive-compulsive disorder.
Conclusions Our results demonstrate genetic maternal effects contributing to the risk of CTD in offspring and also highlight new sources of overlapping risk between CTD and obsessive-compulsive disorder.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by a grant from the Mindich Child Health and Development Institute (DEG), the Friedman Brain Institute (DEG), and the Beatrice and Samuel A. Seaver Foundation (DEG, SS, JDB, BM), Icahn School of Medicine at Mount Sinai, New York, NY; the Mindworks Charitable Lead Trust (DEG); the Stanley Center for Psychiatric Research DEG and JDB).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
not relevant
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available on request from the corresponding author, [DG]. The data are not publicly available.
